28
12, 2024
23
03, 2024
22
03, 2024
19
03, 2024
16
03, 2024
27
02, 2024
20
02, 2024
20
02, 2024
14
02, 2024
Lorenza Rimassa et al., Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
adlitterio663392024-02-14T14:34:18+01:00
11
02, 2024